Interactive Brokers Group And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Interactive Brokers Group (IBKR), Research Solutions (RSSS), IDEXX Laboratories (IDXX) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Interactive Brokers Group (IBKR)

16.5% sales growth and 20.78% return on equity

Interactive Brokers Group, Inc. operates as an automated electronic broker worldwide. The company specializes in routing, executing, and processing trades in stocks, options, futures, foreign exchange instruments, bonds, mutual funds, exchange traded funds (ETFs), metals, and cryptocurrencies. It also custodies and services accounts for hedge and mutual funds, ETFs, registered investment advisors, proprietary trading groups, introducing brokers, and individual investors. In addition, it offers custody, prime brokerage, securities, and margin lending services. The company serves institutional and individual customers through approximately 150 electronic exchanges and market centers. Interactive Brokers Group, Inc. was founded in 1977 and is headquartered in Greenwich, Connecticut.

Earnings Per Share

As for profitability, Interactive Brokers Group has a trailing twelve months EPS of $2.84.

PE Ratio

Interactive Brokers Group has a trailing twelve months price to earnings ratio of 30.15. Meaning, the purchaser of the share is investing $30.15 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.78%.

Yearly Top and Bottom Value

Interactive Brokers Group’s stock is valued at $85.54 at 11:22 EST, way under its 52-week high of $95.59 and way above its 52-week low of $62.70.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Aug 30, 2023, the estimated forward annual dividend rate is 0.4 and the estimated forward annual dividend yield is 0.46%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 48.8%, now sitting on 3.9B for the twelve trailing months.

2. Research Solutions (RSSS)

14.8% sales growth and 9.36% return on equity

Research Solutions, Inc., through its subsidiaries, provides cloud-based software-as-a-service research platform. The company is also involved in the transactional sale of published scientific, technical, and medical (STM) content managed, sourced, and delivered through the Transactions platform. Its solutions enable life science and other research intensive organizations to accelerate their research and development activities with access and management STM articles used throughout the intellectual property development lifecycle. The company was formerly known as Derycz Scientific, Inc. and changed its name to Research Solutions, Inc. in March 2013. Research Solutions, Inc. was founded in 2006 and is based in Henderson, Nevada.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.36%.

Volume

Today’s last reported volume for Research Solutions is 1228350 which is 2732.33% above its average volume of 43369.

Revenue Growth

Year-on-year quarterly revenue growth grew by 16.3%, now sitting on 37.7M for the twelve trailing months.

3. IDEXX Laboratories (IDXX)

10.6% sales growth and 102.06% return on equity

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Earnings Per Share

As for profitability, IDEXX Laboratories has a trailing twelve months EPS of $9.52.

PE Ratio

IDEXX Laboratories has a trailing twelve months price to earnings ratio of 45.02. Meaning, the purchaser of the share is investing $45.02 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 102.06%.

Moving Average

IDEXX Laboratories’s worth is way below its 50-day moving average of $492.46 and way under its 200-day moving average of $480.79.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 10.2% and 9.8%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

IDEXX Laboratories’s EBITDA is 144.94.

4. Corporate Office Properties Trust (OFC)

9.2% sales growth and 11.16% return on equity

COPT is a REIT that owns, manages, leases, develops and selectively acquires office and data center properties. The majority of its portfolio is in locations that support the United States Government and its contractors, most of whom are engaged in national security, defense and information technology (“IT”) related activities servicing what the Company believes are growing, durable, priority missions (“Defense/IT Locations”). The Company also owns a portfolio of office properties located in select urban submarkets in the Greater Washington, DC/Baltimore region with durable Class-A office fundamentals and characteristics (“Regional Office Properties”). As of June 30, 2023, the Company derived 90% of its core portfolio annualized rental revenue from Defense/IT Locations and 10% from its Regional Office Properties. As of the same date and including 24 properties owned through unconsolidated joint ventures, COPT's core portfolio of 192 properties encompassed 22.9 million square feet and was 95% leased.

Earnings Per Share

As for profitability, Corporate Office Properties Trust has a trailing twelve months EPS of $1.68.

PE Ratio

Corporate Office Properties Trust has a trailing twelve months price to earnings ratio of 14.85. Meaning, the purchaser of the share is investing $14.85 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.16%.

Sales Growth

Corporate Office Properties Trust’s sales growth is 10.9% for the current quarter and 9.2% for the next.

5. Calix (CALX)

8.7% sales growth and 6.53% return on equity

Calix, Inc., together with its subsidiaries, provides cloud and software platforms, and systems and services in the United States, the Middle East, Canada, Europe, the Caribbean, and internationally. The company's cloud and software platforms, and systems and services enable communication service providers (CSPs) to provide a range of services. It provides Calix Cloud platform, a role-based analytics platform comprising Calix Marketing Cloud, Calix Support Cloud, and Calix Operations Cloud, which are configurable to display role-based insights and enable CSPs to anticipate and target new revenue-generating services and applications through mobile application. The company also offers EXOS, a carrier class smart home and business operating system that supports residential, business, and mobile subscribers; and AXOS, an operating system for access networks that allows a service provider to deliver all services on a single, elastic, converged access network that is always on, simple to operate, and quick to deploy. It offers its products through its direct sales force and resellers. Calix, Inc. was incorporated in 1999 and is headquartered in San Jose, California.

Earnings Per Share

As for profitability, Calix has a trailing twelve months EPS of $0.64.

PE Ratio

Calix has a trailing twelve months price to earnings ratio of 71.45. Meaning, the purchaser of the share is investing $71.45 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.53%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 29.2%, now sitting on 991.86M for the twelve trailing months.

Moving Average

Calix’s value is above its 50-day moving average of $44.80 and way under its 200-day moving average of $51.55.

6. Evertec (EVTC)

6.2% sales growth and 42.74% return on equity

EVERTEC, Inc. engages in transaction processing business in Latin America and the Caribbean. The company operates through Payment Services – Puerto Rico & Caribbean; Payment Services – Latin America; Merchant Acquiring; Business Solutions, and Corporate and Other segments. It provides merchant acquiring services, which enable point of sales and e-commerce merchants to accept and process electronic methods of payment, such as debit, credit, prepaid, and electronic benefit transfer (EBT) cards. The company also offers payment processing services that enable financial institutions and other issuers to manage, support, and facilitate the processing for credit, debit, prepaid, automated teller machines, and EBT card programs; credit and debit card processing, authorization and settlement, and fraud monitoring and control services to debit or credit issuers; and EBT services. In addition, it provides business process management solutions comprising core bank processing, network hosting and management, IT consulting, business process outsourcing, item and cash processing, and fulfillment solutions to financial institutions, and corporate and government customers. Further, the company owns and operates the ATH network, an automated teller machine and personal identification number debit networks. It manages a system of electronic payment networks that process approximately three billion transactions. The company sells and distributes its services primarily through direct sales force. It serves financial institutions, merchants, corporations, and government agencies. EVERTEC, Inc. was founded in 1988 and is headquartered in San Juan, Puerto Rico.

Earnings Per Share

As for profitability, Evertec has a trailing twelve months EPS of $3.34.

PE Ratio

Evertec has a trailing twelve months price to earnings ratio of 11.14. Meaning, the purchaser of the share is investing $11.14 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 42.74%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 634.48M for the twelve trailing months.

Moving Average

Evertec’s value is below its 50-day moving average of $39.35 and higher than its 200-day moving average of $35.80.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Evertec’s EBITDA is 4.14.

7. AMETEK (AME)

5.9% sales growth and 16.43% return on equity

AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices in North America, Europe, Asia, and South America. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.Its EMG segment offers engineered electrical connectors and electronics packaging to protect sensitive devices and mission-critical electronics; precision motion control products for data storage, medical devices, business equipment, automation, and other applications; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for use in thermal management, military, commercial aircraft, and military ground vehicles; and motors for use in commercial appliances, fitness equipment, food and beverage machines, hydraulic pumps, and industrial blowers. This segment also operates a network of aviation maintenance, repair, and overhaul facilities. In addition, the company offers clinical and educational communication solutions. AMETEK, Inc. was incorporated in 1930 and is headquartered in Berwyn, Pennsylvania.

Earnings Per Share

As for profitability, AMETEK has a trailing twelve months EPS of $5.33.

PE Ratio

AMETEK has a trailing twelve months price to earnings ratio of 27.53. Meaning, the purchaser of the share is investing $27.53 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.43%.

Moving Average

AMETEK’s value is under its 50-day moving average of $155.73 and below its 200-day moving average of $147.60.

Sales Growth

AMETEK’s sales growth is 9.8% for the ongoing quarter and 5.9% for the next.

Volume

Today’s last reported volume for AMETEK is 310549 which is 66.15% below its average volume of 917660.

Earnings Before Interest, Taxes, Depreciation, and Amortization

AMETEK’s EBITDA is 94.33.

Leave a Reply

Your email address will not be published. Required fields are marked *